Alexion Pharmaceuticals, Inc. · 3 days ago
Executive District Sales Manager, R&I, Primary Care, San Francisco
AstraZeneca is a global biopharmaceutical company focused on delivering life-changing medicines. The District Sales Manager for the Primary Care Team will be responsible for driving sales performance, coaching sales representatives, and developing innovative sales strategies to positively impact patient outcomes.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Demonstrates strong understanding of pharmaceutical products, disease states and treatment guidelines within the primary care setting
Possesses and demonstrates a solid grasp of sales metrics, market analysis, and budget management within the primary care environment
Shares insights to guide brand strategy
Actively engages in coaching and development of sales representatives to enhance their performance and professional growth, including in field with customer engagement
Cultivates a collaborative and performance-driven team environment, setting clear expectations and providing necessary support for sales representatives to excel
Actively seeks out opportunities for growth, leveraging market insights and customer feedback to drive innovative sales strategies
Enables team to gain access via multiple selling channels, leveraging relevant technology to achieve impact
Qualification
Required
Bachelor's Degree
3+ yrs Demonstrated Sales, B2B, or Commercial experience or a combination of: pharmaceutical, healthcare, scientific, clinical, institutional, or related industry
Proven leadership capabilities and/or people management experience
A valid driver's license and safe driving record
Demonstrates strong understanding of pharmaceutical products, disease states and treatment guidelines within the primary care setting
Possesses and demonstrates a solid grasp of sales metrics, market analysis, and budget management within the primary care environment
Shares insights to guide brand strategy
Actively engages in coaching and development of sales representatives to enhance their performance and professional growth, including in field with customer engagement
Cultivates a collaborative and performance-driven team environment, setting clear expectations and providing necessary support for sales representatives to excel
Actively seeks out opportunities for growth, leveraging market insights and customer feedback to drive innovative sales strategies
Enables team to gain access via multiple selling channels, leveraging relevant technology to achieve impact
Clinical Acumen: Deep understanding of common primary care pharmaceutical products, disease states, and treatment guidelines prevalent in primary care settings
Business Acumen: Comprehensive knowledge of the primary care market dynamics, including budget considerations, formulary access, and healthcare provider engagement
Coaching Excellence: Expertise in coaching and developing a team, with a focus on building strong relationships with primary care physicians and healthcare providers to drive positive patient outcomes
Build High-Performing teams: Proven ability to set direction and drive accountability to build high performing teams
Growth & Innovation Mindset: Ability to foster a growth mindset and learning agility by leveraging new technology and data insights
Benefits
Qualified retirement programs
Paid time off (i.e., vacation, holiday, and leaves)
Health, dental, and vision coverage in accordance with the terms of the applicable plans
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
H1B Sponsorship
Alexion Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (49)
2024 (57)
2023 (51)
2022 (29)
2021 (27)
2020 (17)
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Recent News
BioWorld Financial Watch
2026-01-17
bloomberglaw.com
2025-12-20
Company data provided by crunchbase